SGLT2 inhibitor empagliflozin downregulates miRNA-34a-5p and targets GREM2 to inactivate hepatic stellate cells and ameliorate non-alcoholic fatty liver disease-associated fibrosis

2023/07/06 by Yunfeng Shen, Lidan Cheng, Minxuan Xu +6 · 2 citations
Medicine · #Liver physiology and pathology #Liver Disease Diagnosis and Treatment #Liver Diseases and Immunity

paper · doi:10.1016/j.metabol.2023.155657

Cited by

• Protective effect of <i>Helicteres isora</i> , an efficient candidate on hepatorenal toxicity and management of diabetes in animal models
• Pathophysiological underpinnings of metabolic dysfunction-associated steatotic liver disease